Operating cash flow increased 140.4%
Operating cash flow changed +140.4% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow changed +140.4% from the comparable as-filed period.
Operating income changed +259.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed +170.2% from the comparable as-filed period.
Operating margin changed +249 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital changed +162.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Current long-term debt changed -91.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capital expenditure changed +58.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory / revenue changed -1653 basis points from the comparable as-filed period.
Net debt changed +33.9% from the comparable as-filed period.
Revenue changed +10.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed -9.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross debt changed +22.6% from the comparable as-filed period.
Reported total debt changed +22.6% from the comparable as-filed period.
Cash / debt changed -687 basis points from the comparable as-filed period.
Total assets changed -4.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed +52 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed -6.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Debt / assets changed +704 basis points from the comparable as-filed period.
Free-cash-flow margin changed +910 basis points from the comparable as-filed period.
Net income changed +343.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed +1007 basis points from the comparable as-filed period.
Trade receivables changed +20.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capex / revenue changed +97 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / revenue changed +742 basis points from the comparable as-filed period.
Stock-based compensation changed -46.6% from the comparable as-filed period.
Current liabilities changed -10.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross profit changed +13.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -10.1% from the comparable as-filed period.
SBC / revenue changed -41 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital / assets changed +185 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Cost of revenue changed +10.2% from the comparable as-filed period.
Shares outstanding changed +1.2% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
R&D / revenue changed -72 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed +105 basis points from the comparable as-filed period.
Research & development changed -5.0% from the comparable as-filed period.
Current ratio changed +4.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.